How is stem cell treatment for Athletes done?
At Stem Cell Mexico, stem cell treatment for athletes is a structured, minimally invasive process built around an accurate diagnosis and a return-to-activity plan.

It begins with a review of your imaging and medical reports, continues with a consultation with the doctor, a written plan and an in-person evaluation, and centers on the local application of allogeneic mesenchymal stem cells (MSCs) from Wharton's jelly of the umbilical cord into the injured joint, tendon or ligament with ultrasound guidance. In some cases, the medical team may also recommend an intravenous (IV) infusion. No autologous cells or other cell sources are used. The number of applications is not fixed in advance and is decided individually, only when there is a medical reason. Treatment is followed by a period of protected activity, structured rehabilitation and follow-up with objective measures. It is offered as a complement to orthopedic care and physical therapy, and results vary between individuals.
This guide walks through each step and explains how the process is adapted to the needs of athletes, from training schedules to anti-doping rules.
Why the process starts with the diagnosis
The success of any treatment for a sports injury depends on treating the right problem. Two athletes with "knee pain" may have entirely different conditions: early osteoarthritis, a meniscus tear, patellar tendinopathy or a ligament injury. Some of these conditions may be suitable for a regenerative approach, some heal with rehabilitation alone, and others, such as complete ligament ruptures, often need surgery. For this reason, the first goal of the process is to confirm the diagnosis and decide whether cell therapy has a reasonable role in your case.
A typical itinerary
A common itinerary for an athlete protocol looks like this:
- Day 1: pickup in the San Diego area, border crossing with a driver, laboratory tests and an in-person consultation with the doctor, including a physical examination of the injured area.
- Day 2: ultrasound-guided local application and, if included in your plan, IV infusion, followed by observation.
- Day 3: check-up with the doctor, discharge instructions with your activity plan and return to San Diego.
Some localized treatments can be completed in a shorter visit. The exact itinerary is confirmed in your written plan.
Step 1: Records review
You send:
- Imaging: MRI, ultrasound or X-rays of the injured area, ideally recent.
- Medical reports from your orthopedic or sports medicine specialist.
- Rehabilitation history, including what has been tried and for how long.
- Previous injections or surgeries in the area, with dates.
- Your training and competition calendar, and whether you are subject to anti-doping testing.
Step 2: Consultation with the doctor
A complimentary phone or video consultation allows the doctor to review your injury, discuss your goals and explain what regenerative treatment can and cannot do. The doctor will discuss:
- Whether your injury is likely to heal with rehabilitation alone or needs surgical evaluation.
- What the evidence shows for your specific condition.
- Realistic expectations about results, which vary between patients.
- How treatment would fit with your season.
Goals are defined in measurable terms, such as reduced pain during specific movements, improved range of motion, strength symmetry or return to a training level.
Step 3: Written plan and preparation
If treatment is appropriate, you receive a written plan describing the cell dose, route, application sites, itinerary, inclusions and costs. Typical preparation instructions include:
- Pausing anti-inflammatory painkillers, alcohol, tobacco and cannabis for about seven days before treatment, and supplements such as omega 3, turmeric and ginger for about five days before, as the doctor indicates.
- Avoiding corticosteroid injections in the area in the weeks before treatment, as the doctor indicates.
- Reducing training load in the days before the procedure.
- Checking anti-doping rules with your team physician or federation if you are a tested athlete.
Step 4: Arrival and evaluation
On arrival, you have blood tests, including a complete blood count, metabolic panel and other tests the doctor considers necessary, and an in-person evaluation. The injured area is examined, and ultrasound is used to confirm the target structures. If anything suggests treatment would not be safe that day, such as an infection, it is postponed.
Step 5: The cell application
The cells
Allogeneic MSCs from Wharton's jelly of donated umbilical cords, obtained after healthy, full-term births with informed consent and donor screening. They are produced in a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release.
Local application with ultrasound guidance
- The skin is cleaned with antiseptic, and a local anesthetic is applied to reduce discomfort.
- Ultrasound is used to visualize the joint, tendon or ligament in real time.
- The cells are injected precisely into the target area.
- A sterile dressing is applied.
Image guidance helps place the cells where they are intended and reduces the risk of injecting into the wrong structure. A review in Frontiers in Immunology describes how the route of delivery changes where MSCs go and how long they remain, which is why local application is preferred for localized injuries.
Optional IV infusion
In some cases, such as multiple injured areas or a significant inflammatory component, the medical team may add a slow IV infusion with monitoring of vital signs. After IV infusion, many cells are temporarily filtered by the lungs, and any effect is believed to come from systemic signaling.
Step 6: Observation
After the procedure, you are observed for a period that depends on your plan. The team watches for pain, swelling and any reaction. If an IV infusion was given, temporary fever is possible and is managed with paracetamol and cooling measures.
Step 7: Discharge and early recovery
Before discharge, you receive written instructions:
- Mild to moderate pain, swelling and stiffness at the injection site are common for a few days.
- Use ice and paracetamol as directed; avoid anti-inflammatory painkillers unless the doctor authorizes them.
- Protect the treated area as instructed; a brace or temporary reduction in load may be recommended.
- Contact the clinic if you notice increasing redness, warmth, fever or severe pain, which could indicate infection.
No treatment is free of risk, and following these instructions is part of making the procedure as safe as possible.
Step 8: Rehabilitation and return to activity
The return-to-activity plan is usually divided into phases:
- Protection (first days): rest of the treated area, gentle range of motion as allowed.
- Progressive loading (weeks 1 to 6, approximately): guided exercises to restore mobility and strength without overloading the tissue.
- Functional training: balance, coordination and movement patterns specific to your sport.
- Return to sport: gradual increase in training intensity, guided by objective criteria rather than a fixed date.
Timelines vary with the injury and tissue treated. Your physical therapist adjusts the program based on how you respond.
Step 9: Follow-up and measurement
Progress is assessed with:
- Pain scores during specific activities.
- Range of motion and strength measurements.
- Validated questionnaires for the affected joint.
- Functional and sport-specific tests.
- Imaging, when your doctor considers it useful.
Follow-up calls are scheduled at regular intervals, and results are shared with your local care team.
Timing treatment around your season
For competitive athletes, timing matters as much as the procedure itself. Treatment is usually best planned during the off-season or a scheduled break, so the treated tissue has time to recover before full training resumes. Treating an injury in the middle of a competitive period can create pressure to return too early, which increases the risk of setbacks. Your team physician, physical therapist and coach should be part of the planning.
Anti-doping considerations
The World Anti-Doping Agency (WADA) Prohibited List includes a category for gene and cell doping (M3), which lists "the use of normal or genetically modified cells" among prohibited methods. If you compete under WADA rules or a professional league's program, consult your team physician and your federation or anti-doping organization before treatment. We can provide documentation describing the product and procedure.
What the evidence says
The 2020 NBA Orthobiologics Consensus Statement recommended clear communication and documentation for cell-based treatments, noting that products vary widely. A 2024 meta-analysis of randomized trials found improvements in pain and function with MSCs for knee osteoarthritis, with variability between studies. For many other sports injuries, evidence comes from smaller studies.
Questions to ask during your evaluation
- What is my exact diagnosis, and is cell therapy reasonable for it?
- Which structures will be treated, and how?
- What will my rehabilitation and return-to-sport plan look like?
- How will results be measured?
- Are there anti-doping considerations for my sport?
Bottom line
Stem cell treatment for athletes at Stem Cell Mexico follows a step-by-step process: records review, consultation, preparation, evaluation, ultrasound-guided application of Wharton's jelly MSCs, observation, structured rehabilitation and follow-up. It is a complement to orthopedic care and physical therapy, with results that vary between individuals. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your injury, goals and medical history.
References
- Cole BJ et al. The 2020 NBA Orthobiologics Consensus Statement. Orthopaedic Journal of Sports Medicine, 2021 (opens in a new tab)
- Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
- Caplan H, Olson SD, Cox CS Jr et al. Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application. Frontiers in Immunology, 2019 (opens in a new tab)
- World Anti-Doping Agency (WADA): The Prohibited List (opens in a new tab)
